Nav: Home

Hospitalizations for heart infection related to drug injection rising across the US

September 01, 2016

BOSTON (Sept. 1, 2016)--Hospitalizations for infective endocarditis, a heart valve infection often attributed to injection drug use, have increased significantly among young adult Americans--particularly in whites and females--according to a new study by researchers from Tufts Medical Center and Tufts University School of Medicine. The findings, published in Open Forum Infectious Diseases on Sept. 1, shed light on the healthcare burdens and shifting demographics associated with the rising national trend of opioid abuse.

Infective endocarditis is a sometimes lethal infection of the heart valves. People born with abnormal valves or older adults who develop valve issues are at increased risk for infective endocarditis, but it can also be triggered by injection drug use, which can introduce bacteria into the blood stream.

The research team found that injection drug use-related infective endocarditis (IDU-IE) represented around 12 percent of all infective endocarditis hospitalizations in the U.S. in 2013, a significant increase from seven percent in 2000. This represents an estimated growth from 3,578 cases to 8,530.

Young adults (ages 15 to 34) accounted for 28 percent of all IDU-IE cases in 2000. This proportion grew to 42 percent in 2013.

When broken down by race, white individuals represented 40 percent of all IDU-IE hospitalizations in 2000. This grew to 69 percent in 2013. This trend was magnified among white young adults, growing in proportion from 57 percent to 80 percent.

Females represented 41 percent of all IDU-IE hospitalizations in 2013, but accounted for 53 percent of young adult IDU-IE hospitalizations.

"As clinicians, we have observed a major increase in young people with opioid addiction cycling in and out of the healthcare system, and many end up with devastating complications of injection drug use like infective endocarditis," said first author Alysse Wurcel, MD, infectious diseases physician at Tufts Medical Center and also an assistant professor at Tufts University School of Medicine. "Our study confirms that this trend is increasing across the U.S. and represents yet another indicator of the challenges we face with the national opioid epidemic."

A shift toward youth

On an average day in the U.S, 78 people die from an overdose involving opioids--including prescription opioid pain relievers and heroin-- a rate that has quadrupled since 1999, according to the U.S. Department of Health and Human Services. The prevalence of injection drug use has grown alongside this epidemic--particularly among younger, white individuals.

The five-year mortality rate for infective endocarditis ranges from 12 to 50 percent of patients. The cumulative expense of care for IDU-IE poses increasing financial burdens for healthcare facilities and insurance companies, as the majority of these patients are unemployed or underemployed, and reliant on publically-funded medical insurance, write the study authors.

"We're seeing a shift toward youth, white youth, and women, and it's likely that we'll continue to see even higher increases. It's a much more suburban problem than most people realize," said senior author Thomas Stopka, PhD, assistant professor of public health and community medicine at Tufts University School of Medicine, who specializes in the epidemiology and geospatial distribution of infectious diseases and substance abuse. "We need to identify these different subgroups and better understand how they are affected by the opioid epidemic and associated complications, so that we can try to design a more comprehensive approach to prevention, intervention, and care."

To determine whether the opioid epidemic was paralleled by cases of infective endocarditis, the team analyzed data from the Nationwide Inpatient Samples--the largest public administrative database for hospital care data in the U.S., which estimates health statistics from more than 35 million inpatient stays each year. The team calculated their estimates by excluding infective endocarditis cases linked to congenital defects, and including cases of reported drug use and young patients with hepatitis C--a strong indicator of injection drug use.

"The current systems we have in place for the opioid epidemic are like bandages for much bigger, oozing wounds," Wurcel said. "The focus should be to catch people in the early stages of addiction, and to try and educate them about how to reduce their risks for disease and, if possible, to initiate drug treatment. Or if not, try to find a way to help them into opioid replacement projects where they can somehow break the cycle they're in. Otherwise this epidemic will continue."
Additional authors of the study are Jordan Anderson, research assistant at the Center for the Evaluation of Value and Risk in Health at Tufts Medical Center; Kenneth K.H. Chui, Ph.D., associate professor, Sally Skinner, senior statistical programmer, and Tamsin A. Knox M.D., associate professor, all in the Department of Public Health and Community Medicine at Tufts University School of Medicine; and David R. Snydman, M.D., chair of the Department of Geographic Medicine and Infectious Diseases at Tufts Medical Center and also professor of medicine at Tufts University School of Medicine and the Clinical & Translational Science program at the Sackler School of Graduate Biomedical Sciences at Tufts.

This research was supported by the National Institutes of Health via the National Center for Advancing Translational Sciences (Tufts Clinical and Translational Research Institute award UL1TR001064); the National Institute of Allergy and Infectious Diseases/NIAID (AI055412-10, AI007438-20); the National Institute on Drug Abuse (R25DA013582-14). The research was also supported the National Lifespan/Tufts/Brown Center for AIDS Research (NIAID P30AI042853).

Wurcel, Alysse G, Anderson, J, Chui KKH, Skinner, S, Knox, TA, Snydman, DR, Stopka, TJ. Increasing Infectious Endocarditis Admissions among Young People Who Inject Drugs. Open Forum Infectious Diseases. Fall 2016; 3 (4). DOI:10.1093/ofid/ofw157

About Tufts University School of Medicine and the Sackler School of Graduate Biomedical Sciences

Tufts University School of Medicine and the Sackler School of Graduate Biomedical Sciences are international leaders in medical and population health education and advanced research. Tufts University School of Medicine emphasizes rigorous fundamentals in a dynamic learning environment to educate physicians, scientists, and public health professionals to become leaders in their fields. The School of Medicine and the Sackler School are renowned for excellence in education in general medicine, the biomedical sciences, and public health, as well as for innovative research at the cellular, molecular, and population health level. The School of Medicine is affiliated with six major teaching hospitals and more than 30 health care facilities. Tufts University School of Medicine and the Sackler School undertake research that is consistently rated among the highest in the nation for its effect on the advancement of medical and prevention science.

About Tufts Medical Center and Floating Hospital for Children

Tufts Medical Center is an exceptional, not-for-profit, 415-bed academic medical center that is home to both a full-service hospital for adults and Floating Hospital for Children. Conveniently located in downtown Boston, the Medical Center is the principal teaching hospital for Tufts University School of Medicine. Floating Hospital for Children is the full-service children's hospital of Tufts Medical Center and the principal pediatric teaching hospital of Tufts University School of Medicine. Tufts Medical Center is affiliated with the New England Quality Care Alliance, a network of more than 1,800 physicians throughout Eastern Massachusetts. For more information, please visit

Tufts University, Health Sciences Campus

Related Public Health Articles:

Public health guidelines aim to lower health risks of cannabis use
Canada's Lower-Risk Cannabis Use Guidelines, released today with the endorsement of key medical and public health organizations, provide 10 science-based recommendations to enable cannabis users to reduce their health risks.
Study clusters health behavior groups to broaden public health interventions
A new study led by a University of Kansas researcher has used national health statistics and identified how to cluster seven health behavior groups based on smoking status, alcohol use, physical activity, physician visits and flu vaccination are associated with mortality.
Public health experts celebrate 30 years of CDC's prevention research solutions for communities with health disparities
It has been 30 years since CDC created the Prevention Research Centers (PRC) Program, currently a network of 26 academic institutions across the US dedicated to moving new discoveries into the communities that need them.
Public health experts support federally mandated smoke-free public housing
In response to a new federal rule mandating smoke-free policies in federally funded public housing authorities, three public health experts applaud the efforts of the US Department of Housing and Urban Development to protect nonsmoking residents from the harmful effects of tobacco exposure.
The Lancet Public Health: UK soft drinks industry levy estimated to have significant health benefits, especially among children
The UK soft drinks industry levy, due to be introduced in April 2018, is estimated to have significant health benefits, especially among children, according to the first study to estimate its health impact, published in The Lancet Public Health.
Social sciences & health innovations: Making health public
The international conference 'Social Sciences & Health Innovations: Making Health Public' is the third event organized as a collaborative endeavor between Maastricht University, the Netherlands, and Tomsk State University, the Russian Federation, with participation from Siberian State Medical University (the Russian Federation).
Columbia Mailman School Awards Public Health Prize to NYC Health Commissioner Dr. Mary T.
Dr. Mary T. Bassett, Commissioner of the New York City Department of Health and Mental Hygiene, was awarded the Frank A.
Poor health literacy a public health issue
America's poor record on health literacy is a public health issue, but one that can be fixed -- not by logging onto the internet but by increased interaction with your fellow human beings, a Michigan State University researcher argues.
Despite health law's bow to prevention, US public health funding is dropping: AJPH study
Although the language of the Affordable Care Act emphasizes disease prevention -- for example, mandating insurance coverage of clinical preventive services such as mammograms -- funding for public health programs to prevent disease have actually been declining in recent years.
'Chemsex' needs to become a public health priority
Chemsex -- sex under the influence of illegal drugs -- needs to become a public health priority, argue experts in The BMJ this week.

Related Public Health Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Climate Crisis
There's no greater threat to humanity than climate change. What can we do to stop the worst consequences? This hour, TED speakers explore how we can save our planet and whether we can do it in time. Guests include climate activist Greta Thunberg, chemical engineer Jennifer Wilcox, research scientist Sean Davis, food innovator Bruce Friedrich, and psychologist Per Espen Stoknes.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...